Canada markets closed

NRx Pharmaceuticals, Inc. (NRXP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.5400+0.0200 (+0.57%)
At close: 04:00PM EDT
3.6400 +0.10 (+2.82%)
After hours: 07:03PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
18,984
13,371
17,027
20,257
10,625
Selling General and Administrative
68,438
14,216
27,308
74,944
11,436
Total Operating Expenses
87,422
27,837
44,335
115,796
51,387
Operating Income or Loss
-87,422
-27,837
-44,335
-115,796
-51,387
Interest Expense
5
120
0
18
56
Total Other Income/Expenses Net
27,388
-2,687
4,332
22,751
-334
Income Before Tax
-59,920
-30,150
-39,754
-93,063
-51,777
Income Tax Expense
-
-
0
0
0
Income from Continuing Operations
-59,920
-30,150
-39,754
-93,063
-51,777
Net Income
-59,920
-30,150
-39,754
-93,063
-51,777
Net Income available to common shareholders
-59,920
-30,159
-39,754
-348,885
-51,777
Basic EPS
-0.50
-4.00
-6.00
-74.40
-15.10
Diluted EPS
-0.50
-4.00
-6.00
-74.40
-15.10
Basic Average Shares
72,203
7,576
6,577
4,692
3,427
Diluted Average Shares
72,203
7,576
6,577
4,692
3,427